Cargando…
Identification of a three-gene expression signature of poor-prognosis breast carcinoma
BACKGROUND: The clinical course of breast cancer is difficult to predict on the basis of established clinical and pathological prognostic criteria. Given the genetic complexity of breast carcinomas, it is not surprising that correlations with individual genetic abnormalities have also been disappoin...
Autores principales: | Bièche, Ivan, Tozlu, Sengül, Girault, Igor, Lidereau, Rosette |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544833/ https://www.ncbi.nlm.nih.gov/pubmed/15606925 http://dx.doi.org/10.1186/1476-4598-3-37 |
Ejemplares similares
-
Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma
por: Bièche, Ivan, et al.
Publicado: (2004) -
Expression analysis of mitotic spindle checkpoint genes in breast carcinoma: role of NDC80/HEC1 in early breast tumorigenicity, and a two-gene signature for aneuploidy
por: Bièche, Ivan, et al.
Publicado: (2011) -
Prognostic value of maspin mRNA expression in ERα-positive postmenopausal breast carcinomas
por: Bièche, I, et al.
Publicado: (2003) -
Update on inflammatory breast cancer
por: Lerebours, Florence, et al.
Publicado: (2005) -
MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?
por: Cizeron-Clairac, Geraldine, et al.
Publicado: (2015)